Avion Pharms Drug Patent Portfolio
Avion Pharms owns 2 orange book drugs protected by 5 US patents Given below is the list of Avion Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11033521 | Levodopa fractionated dose composition and use | 28 Mar, 2039 | Active |
| US11439613 | Levodopa fractionated dose composition and use | 28 Mar, 2039 | Active |
| US11819485 | Levodopa fractionated dose composition and use | 28 Mar, 2039 | Active |
| US7838042 | Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions | 01 Jun, 2027 | Active |
| US6716814 | Enhancing solubility of iron amino acid chelates and iron proteinates | 16 Aug, 2021 | Expired |
Latest Legal Activities on Avion Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Avion Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail Patent eGrant Notification | 21 Nov, 2023 | US11819485 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 21 Nov, 2023 | US11819485 |
| Patent eGrant Notification | 21 Nov, 2023 | US11819485 |
|
Email Notification
Critical
| 21 Nov, 2023 | US11819485 |
| Recordation of Patent eGrant | 21 Nov, 2023 | US11819485 |
|
Recordation of Patent Grant Mailed
Critical
| 21 Nov, 2023 | US11819485 |
|
Email Notification
Critical
| 02 Nov, 2023 | US11819485 |
|
Issue Notification Mailed
Critical
| 01 Nov, 2023 | US11819485 |
| Dispatch to FDC | 16 Oct, 2023 | US11819485 |
|
Application Is Considered Ready for Issue
Critical
| 16 Oct, 2023 | US11819485 |
|
Issue Fee Payment Received
Critical
| 11 Oct, 2023 | US11819485 |
|
Issue Fee Payment Verified
Critical
| 11 Oct, 2023 | US11819485 |
|
Email Notification
Critical
| 16 Aug, 2023 | US11819485 |
|
Electronic Review
Critical
| 16 Aug, 2023 | US11819485 |
|
Mail Notice of Allowance
Critical
| 16 Aug, 2023 | US11819485 |
Avion Pharms's Drug Patent Litigations
Avion Pharms's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Dec 23, 2008, against patent number US7838042. The petitioner , challenged the validity of this patent, with Max R. Motyka et al as the respondent. Click below to track the latest information on how companies are challenging Avion Pharms's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US7838042 | December, 2008 |
Decision
(06 Apr, 2010)
| Max R. Motyka et al | |
Avion Pharms's Family Patents
Avion Pharms Drug List
Given below is the complete list of Avion Pharms's drugs and the patents protecting them.
1. Balcoltra
Balcoltra is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7838042 | Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
01 Jun, 2027
(2 years from now)
| Active |
| US6716814 | Enhancing solubility of iron amino acid chelates and iron proteinates |
16 Aug, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Balcoltra's drug page
2. Dhivy
Dhivy is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11033521 | Levodopa fractionated dose composition and use |
28 Mar, 2039
(14 years from now)
| Active |
| US11439613 | Levodopa fractionated dose composition and use |
28 Mar, 2039
(14 years from now)
| Active |
| US11819485 | Levodopa fractionated dose composition and use |
28 Mar, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dhivy's drug page